Reltecimod, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ153)

Product Quick View

Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs).

Overview
SynonymsAB-103; Reltecimod; AB103; TREM-1 antagonist peptide
SourceNot specified
CAS1447799-33-8
Molecular FormulaC46H72N10O15S
Molecular Weight1037.19
Sequence{d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala}
Sequence Shortening{d-Ala}-SPMLVAYD-{d-Ala}
ActivityGram-positive bacteria; Gram-negative bacteria; Fungi; ROS; LPS; Inflammation
Physical StatePowder
Purity>98%
StorageThe power can be stored at 4°C for 2 years or at -20°C for 3 years.

For Research Use Only.

Related products
Online Inquiry
Name:
Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.